ACHILLES THERAPEUTICS PLC

(ACHL)
  Report
Delayed Nasdaq  -  05/19 04:00:00 pm EDT
2.410 USD   +2.99%
05/17European ADRs Move Higher in Tuesday Trading
MT
05/10Achilles Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
AQ
05/10Achilles Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on ACHILLES THERAPEUTICS PLC
03/02Oppenheimer Adjusts Achilles Therapeutics Price Target to $19 From $23, Maintains Outpe..
MT
2021ACHILLES THERAPEUTICS : JP Morgan Initiates Achilles Therapeutics at Underweight Rating Wi..
MT
2021ACHILLES THERAPEUTICS : Oppenheimer Initiates Coverage on Achilles Therapeutics With Outpe..
MT
2021ACHILLES THERAPEUTICS : Chardan Initiates Coverage on Achilles Therapeutics With Buy Ratin..
MT
2021ACHILLES THERAPEUTICS : BofA Securities Starts Achilles Therapeutics at Buy With $20 Price..
MT
2021ACHILLES THERAPEUTICS : Piper Sandler Starts Achilles Therapeutics at Overweight With $25 ..
MT
Upcoming event on ACHILLES THERAPEUTICS PLC